Rogaine Men's 5% Minoxidil Foam for Hair Regrowth, Topical Hair Loss Treatment to Regrow Fuller, Thicker Hair, Unscented, 4-Month Supply, 4 x 2.11 oz

REGROW THINNING HAIR: 4-month supply (three, 2.11-ounce bottles) of Men's Rogaine Unscented 5% Minoxidil Foam topical hair loss treatment scientifically proven to regrow hair & reverse hereditary hair loss5% MINOXIDIL: Formulated with 5% minoxidil, this unscented topical foam from the #1 dermatologist recommended hair regrowth brand to treat thinning hair & is clinically proven to improve hair regrowth by 4x by 16 weeks* *vs controlTRICHO-PRIME TECHNOLOGY: This hair regrowth treatment features Rogaine's Tricho-Prime technology to uniquely condition the scalp to prevent dryness & irritation, plus, exfoliate skin to keep hair follicles open for ample minoxidil absorptionDON'T WAIT: This minoxidil foam works in five ways to reactivate your natural hair growth cycle to grow fuller, thicker hair. Start applying at the first signs of hair thinning to help slow the hair loss processEASY TO APPLY: The easy-to-apply topical hair loss treatment is designed to fit into your daily hair care routine. Simply apply half of a cap full of foam from the #1 hair regrowth brand for over 3 decades to your scalp twice daily for fuller hairBergfeld W, et al. Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5% Minoxidil Foam 04 February 2005. Based on the 2022 Dermatologist Recommendation Study conducted by Ipsos Healthcare, Rogaine is the #1 recommended OTC hair regrowth brand. Bland HE, Kupiecki RM, Sinkula MS. Efficacy comparison of 5% minoxidil solution, ROGAINE® Topical Solution and placebo in male pattern baldness. Upjohn Technical Report 9157-91-028, August 23, 1991 (Revised October 24, 1994 & October 27, 1995). Price VH, Menefree E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J am Acad Dermatol.1999;41:717-721. Rogaine Ask Suzy survey fielded to 224 total participating males with stage 2 hair loss or greater, ages 18-54, fielded from Oct 31-Nov 14, 2023